OM:REDS

Stock Analysis Report

Executive Summary

Redsense Medical AB (publ) provides blood loss detection devices primarily in Europe and the United States.

Snowflake

Fundamentals

Exceptional growth potential with mediocre balance sheet.

Risks

  • Redsense Medical has significant price volatility in the past 3 months.
  • Redsense Medical is covered by less than 3 analysts.

Share Price & News

How has Redsense Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OM:REDS

-0.1%

SE Medical Equipment

-0.03%

SE Market


1 Year Return

-5.1%

OM:REDS

17.7%

SE Medical Equipment

-2.3%

SE Market

REDS underperformed the Medical Equipment industry which returned 34.1% over the past year.

REDS underperformed the Market in Sweden which returned 4.3% over the past year.


Share holder returns

REDSIndustryMarket
7 Day0%-0.1%-0.03%
30 Day-10.8%0.7%-3.7%
90 Day-18.6%8.4%-1.4%
1 Year-5.1%-5.1%18.8%17.7%1.8%-2.3%
3 Year-44.8%-44.8%55.5%35.7%24.6%6.2%
5 Yearn/a46.3%20.8%45.0%14.2%

Price Volatility Vs. Market

How volatile is Redsense Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Redsense Medical undervalued based on future cash flows and its price relative to the stock market?

30.31x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Redsense Medical's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Redsense Medical's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Redsense Medical is loss making, we can't compare its value to the SE Medical Equipment industry average.

Redsense Medical is loss making, we can't compare the value of its earnings to the Sweden market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Redsense Medical, we can't assess if its growth is good value.


Price Based on Value of Assets

Redsense Medical is overvalued based on assets compared to the SE Medical Equipment industry average.


Next Steps

Future Growth

How is Redsense Medical expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

99.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Redsense Medical's revenue is expected to grow significantly at over 20% yearly.

Redsense Medical's earnings are expected to grow significantly at over 20% yearly.

Redsense Medical's revenue growth is expected to exceed the Sweden market average.

Redsense Medical's earnings growth is expected to exceed the Sweden market average.

Redsense Medical's earnings growth is expected to exceed the low risk savings rate of 0.4%.


Earnings per Share Growth Estimates


Future Return on Equity

Redsense Medical is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).


Next Steps

Past Performance

How has Redsense Medical performed over the past 5 years?

-26.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Redsense Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Redsense Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Redsense Medical's 1-year growth to the SE Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Redsense Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Redsense Medical has efficiently used its assets last year compared to the SE Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Redsense Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

  • Explore strong past performing companies in the Healthcare industry.

Financial Health

How is Redsense Medical's financial position?


Financial Position Analysis

Redsense Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Redsense Medical's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Redsense Medical's level of debt (75.4%) compared to net worth is high (greater than 40%).

Redsense Medical had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Redsense Medical has less than a year of cash runway based on current free cash flow.

Redsense Medical has less than a year of cash runway if free cash flow continues to grow at historical rates of 14.9% each year.


Next Steps

Dividend

What is Redsense Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Redsense Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Redsense Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Redsense Medical has not reported any payouts.

Unable to verify if Redsense Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Redsense Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Redsense Medical's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average board tenure


CEO

Patrik Byhmer (52yo)

0.0yrs

Tenure

0

Mr. Patrik Byhmer serves as the Chief Executive Officer & Founder of Redsense Medical AB (publ). Mr. Byhmer has experience in helping medical companies to grow global - his network extends across the Europ ...


Board Age and Tenure

2.3yrs

Average Tenure

58yo

Average Age

The average tenure for the Redsense Medical board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month insider trading information.


Recent Insider Transactions

Buykr3,11729 May 19
Jörgen Hegbrant
EntityIndividual
Role
Member of the Board of Directors
Director
Shares286
Max Pricekr10.90
Buykr11,99912 Oct 18
Patrik Byhmer
EntityIndividual
Role
Chief Executive Officer
CEO & Founder
Shares1,000
Max Pricekr12.00
Buykr12,20010 Oct 18
Patrik Byhmer
EntityIndividual
Role
Chief Executive Officer
CEO & Founder
Shares1,000
Max Pricekr12.20
Buykr17,34805 Oct 18
Patrik Byhmer
EntityIndividual
Role
Chief Executive Officer
CEO & Founder
Shares1,399
Max Pricekr12.40
Buykr30,37504 Oct 18
Patrik Byhmer
EntityIndividual
Role
Chief Executive Officer
CEO & Founder
Shares2,500
Max Pricekr12.15
Buykr119,50003 Oct 18
Patrik Byhmer
EntityIndividual
Role
Chief Executive Officer
CEO & Founder
Shares10,000
Max Pricekr11.95

Ownership Breakdown


Management Team

  • Jarl Ahlmén

    Chief Medical Consultant

    • Tenure: 0.0yrs
  • Patrik Byhmer (52yo)

    CEO & Founder

    • Tenure: 0.0yrs

Board Members

  • Jörgen Hegbrant

    Director

    • Tenure: 2.3yrs
  • Susanne Olauson (48yo)

    Director

    • Tenure: 6.3yrs
  • Bo Unéus (58yo)

    Chairman of the Board

    • Tenure: 2.3yrs
  • Klas Arildsson (58yo)

    Director

    • Tenure: 2.3yrs

Company Information

Redsense Medical AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Redsense Medical AB (publ)
  • Ticker: REDS
  • Exchange: OM
  • Founded: 2000
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr122.870m
  • Shares outstanding: 11.02m
  • Website: https://www.redsensemedical.com

Location

  • Redsense Medical AB (publ)
  • Gyllenhammarsväg 26
  • Halmstad
  • Halland County
  • 302 92
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
REDSOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKJun 2015

Biography

Redsense Medical AB (publ) provides blood loss detection devices primarily in Europe and the United States. The company offers an alarm system that includes an alarm unit, an extension fiber, and a non-inv ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/05/04 22:48
End of Day Share Price2019/05/02 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.